Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Abstract Text:

    zeyu xiongZeyu Xiong,yan yanYan Yan,enli liuEnli Liu,richard t silverRichard T Silver,srdan verstovsekSrdan Verstovsek,fan yangFan Yang,hong wangHong Wang,josef prchalJosef Prchal,xiao-feng yangXiao-Feng Yang,

    We attempted to determine whether the immune reactions elicited by aberrantly expressed testis antigens contribute to the beneficial responses to interferon (IFN)-alpha therapy and other therapies in patients with polycythemia vera (PV). We screened a human testis cDNA library using SEREX (serological analysis of tumor antigens by screening an expression cDNA library with sera from three patients with PV who had undergone IFN-alpha-induced or other therapeutics-induced remission). We identified two novel PV associated tumor antigens, PV65 (eIF-2alpha) and PV13 (protamine 2). These 2 antigens elicited IgG antibody reactions in a subset of PV patients but not in healthy donors, suggesting that they are authentic tumor antigens. Increased phosphorylation of PV65 in response to stimulation of IFN-alpha, and upregulation of PV13 in tumor cells might enhance their abilities in elicitation of immune reactions in patients. These findings provide new insights into the mechanism underlying the regulation of the self-antigen repertoire in eliciting anti-tumor immune reactions in patients with polycythemia vera, and suggest their potential as the targets of novel immunotherapy.

    Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Publishing Authors By Initials

    z xiongZ Xiong,y yanY Yan,e liuE Liu,rt silverRT Silver,s verstovsekS Verstovsek,f yangF Yang,h wangH Wang,j prchalJ Prchal,xf yangXF Yang,

    For similar cells: cells, cultured: cell line: cell line, tumor: u937 cells research abstracts see: cells: cells, cultured: cell line: cell line, tumor: u937 cells research

    PUBMED ID PMID:

    MEDLINE DATE:

    Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical immunology (Orlando, Fla.)

    VOLUME: 122

    Page Numbers: 279-87

    Journal Abbreviation: Clin. Immunol.

    ISSN: 1521-6616

    DAY: 17

    MONTH: 11

    YEAR: 2006

    Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883537

    Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Keywords Mesh Terms:

    KEYWORDS: U937 Cells

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera. Information

    Substance Name: protamine 2

    Registry Number: 0

    Grant and Affiliation Information for Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

    AFFILIATION: Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: AI054514

    ACRONYM: AI

    MEDLINETA: Clin Immunol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News